Market Overview

UPDATE: ImmuCell Raises Q2 Sales Outlook


ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, today announced an improvement in its product sales forecast guidance for the second quarter of 2015 to an increase in the range of 25% to 30% in comparison to the second quarter of 2014, from the previously announced anticipated decrease in the range of 15% to 20%, subject to the risks and uncertainties identified below under the "Safe Harbor Statement".

Michael F. Brigham, President and CEO, commented, "This increase in guidance is due primarily to a better-than-expected inventory production schedule allowing us to address a portion of the pent-up demand that is building for First Defense®. Despite shipping all the First Defense®that we can produce, we still have a backlog of orders waiting to be shipped aggregating approximately $1.45 million as of June 30, 2015 (as compared to $1.28 million as of March 31, 2015). We remain on track to complete all of our planned manufacturing capacity expansion investments by the first quarter of 2016. We expect year-to-date product sales to be approximately 40% higher than the first six months of 2014, and we continue to expect positive year-to-date sales growth throughout 2015, in comparison to the same periods in 2014."

Posted-In: News Guidance


Related Articles (ICCC)

View Comments and Join the Discussion!

Intersect ENT Enrolls First Patient in Pivotal Study to Evaluate the NOVA Sinus Implant

Yingli Solar and Partners Power School and Clinic in Rural Laos